A year ago, three firms were racing to bring transcatheter aortic valve replacement devices to market. The FTC said allowing ...

In its own statement, Edwards said it disagrees with the FTC’s belief that the acquisition will limit access to a new therapy ...

The FTC asserts that Edwards acquisition of JenaValve, given it now owns rival TAVR-AR firm JC Medical, will eliminate ...

Edwards Lifesciences and JenaValve said they remained committed to completing the deal and would defend the case in court.

The US Federal Trade Commission filed suit Wednesday to block Edwards Lifesciences Corp. from acquiring medical device maker JenaValve Technology Inc.